Disturbances of parathyroid hormone–vitamin D axis in non-cholestatic chronic liver disease: a cross-sectional study

[1] Pappa HM(2008)Vitamin D status in gastrointestinal and liver disease Curr Opin Gastroenterol 24 176-183

[2] Bern E(1996)Osteodystrophy in patients with chronic hepatitis and liver cirrhosis J Gastroenterol 31 669-678

[3] Kamin D(2009)Bone mineral density and disorders of mineral metabolism in chronic liver disease World J Gastroenterol 15 3516-3522

[4] Grand RJ(1998)Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis Hepatology 28 695-699

[5] Tsuneoka K(2003)AGA technical review on osteoporosis in hepatic disorders Gastroenterology 125 941-966

[6] Tameda Y(2006)Assessment of bone metabolism and mineral density in chronic viral hepatitis Turk J Gastroenterol 17 260-266

[7] Takase K(2007)Impairment of bone mass development in children with chronic cholestatic liver disease Clin Endocrinol 66 518-523

[8] Nakano T(2001)Calcium–parathyroid hormone–vitamin D axis and metabolic bone disease in chronic viral liver disease J Gastroenterol Hepatol 16 1022-1027

[9] George J(2009)Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells J Endocrinol 200 207-221

[10] Ganesh HK(2008)Vitamin D’s role in cell proliferation and differentiation Nutr Rev 66 S116-S124

[1] Pappa HM(2008)Vitamin D status in gastrointestinal and liver disease Curr Opin Gastroenterol 24 176-183

[2] Bern E(1996)Osteodystrophy in patients with chronic hepatitis and liver cirrhosis J Gastroenterol 31 669-678

[3] Kamin D(2009)Bone mineral density and disorders of mineral metabolism in chronic liver disease World J Gastroenterol 15 3516-3522

[4] Grand RJ(1998)Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis Hepatology 28 695-699

[5] Tsuneoka K(2003)AGA technical review on osteoporosis in hepatic disorders Gastroenterology 125 941-966

[6] Tameda Y(2006)Assessment of bone metabolism and mineral density in chronic viral hepatitis Turk J Gastroenterol 17 260-266

[7] Takase K(2007)Impairment of bone mass development in children with chronic cholestatic liver disease Clin Endocrinol 66 518-523

[8] Nakano T(2001)Calcium–parathyroid hormone–vitamin D axis and metabolic bone disease in chronic viral liver disease J Gastroenterol Hepatol 16 1022-1027

[9] George J(2009)Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells J Endocrinol 200 207-221

[10] Ganesh HK(2008)Vitamin D’s role in cell proliferation and differentiation Nutr Rev 66 S116-S124